109 related articles for article (PubMed ID: 15295044)
21. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.
Fiocchi C
J Clin Invest; 2001 Aug; 108(4):523-6. PubMed ID: 11518725
[No Abstract] [Full Text] [Related]
22. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
[TBL] [Abstract][Full Text] [Related]
23. From receptor to nucleus: the Smad pathway.
Baker JC; Harland RM
Curr Opin Genet Dev; 1997 Aug; 7(4):467-73. PubMed ID: 9309176
[TBL] [Abstract][Full Text] [Related]
24. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.
Ulloa L; Doody J; Massagué J
Nature; 1999 Feb; 397(6721):710-3. PubMed ID: 10067896
[TBL] [Abstract][Full Text] [Related]
26. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
27. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
29. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
30. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
33. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
Javelaud D; Mauviel A
Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
[TBL] [Abstract][Full Text] [Related]
34. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
37. Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-Beta signaling in aged human skin in vivo.
Son ED; Lee JY; Lee S; Kim MS; Lee BG; Chang IS; Chung JH
J Invest Dermatol; 2005 Jun; 124(6):1149-61. PubMed ID: 15955089
[TBL] [Abstract][Full Text] [Related]
38. A tumor-suppressing duo: TGFbeta and activin modulate a similar transcriptome.
Schnepp R; Hua X
Cancer Biol Ther; 2003; 2(2):171-2. PubMed ID: 12750557
[No Abstract] [Full Text] [Related]
39. Intracellular signaling: Fleshing out the TGFbeta pathway.
Padgett RW
Curr Biol; 1999 Jun; 9(11):R408-11. PubMed ID: 10359694
[TBL] [Abstract][Full Text] [Related]
40. Downstream factors in transforming growth factor-beta family signaling.
Visser JA; Themmen AP
Mol Cell Endocrinol; 1998 Nov; 146(1-2):7-17. PubMed ID: 10022758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]